of primary tumor cells isolated from patients , the cells of 5 of 15 patients with acute nonlymphocytic leukemia ( anll ) , 5 of 9 patients with acute lymphocytic leukemia ( all ) , 2 of 3 patients with chronic phase chronic myelogenous leukemia ( cml ) , 2 of 3 patients with blastic phase cml , 1 patient with hairy cell leukemia , and 6 patients with diffuse non-hodgkin 's lymphoma were sensitive to ifn-activated pbmc of healthy donors , whereas the cells of 3 of the anll patients , 2 of the all patients , and 3 of the lymphoma patients were sensitive to unstimulated pbmc .
C0007634
the cells
C1321301
pbmc